BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1725631)

  • 61. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan.
    Khan M; Husain M; Yano M; Hashizume K; Yousuf M; Tanaka E; Matsumoto A; Furuta S; Kiyosawa K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():28-31. PubMed ID: 7689505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum.
    Ellis LA; Brown D; Conradie JD; Paterson A; Sher R; Millo J; Theodossiadou E; Dusheiko GM
    J Med Virol; 1990 Dec; 32(4):249-51. PubMed ID: 2127942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 64. Hepatitis C virus infection in haemodialysis patients.
    Roger SD; Crewe E; Cunningham A; Harris DC
    Aust N Z J Med; 1991 Feb; 21(1):22-4. PubMed ID: 1852154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.
    Stevens CE; Taylor PE; Pindyck J; Choo QL; Bradley DW; Kuo G; Houghton M
    JAMA; 1990 Jan; 263(1):49-53. PubMed ID: 2104548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
    Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low overlap between anti-HCV and anti-HBc in Japanese.
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Transfusion; 1991 Jan; 31(1):88-9. PubMed ID: 1846051
    [No Abstract]   [Full Text] [Related]  

  • 71. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.
    Colin C; Vergnon P; Jullien AM; Excoffier S; Matillon Y; Trepo C
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):220-7. PubMed ID: 9131325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-A non-B hepatitis and hepatitis C virus.
    Katz L
    Iowa Med; 1992 Feb; 82(2):71-3. PubMed ID: 1313402
    [No Abstract]   [Full Text] [Related]  

  • 73. Comparison of assays for anti-HBc in blood donors.
    Schmidt PJ; Leparc GF; Samia CT
    Transfusion; 1988; 28(4):389-91. PubMed ID: 3388486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of central Brazil.
    Martins RM; Vanderborght BO; Rouzere CD; Santana CL; Santos CO; Mori DN; Ferreira RG; Yoshida CF
    Rev Inst Med Trop Sao Paulo; 1994; 36(6):501-6. PubMed ID: 7569623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sashima epidemic hepatitis: epidemiological feature and anti-HCV status].
    Wakayama Y; Aramaki T
    Nihon Rinsho; 1991 Feb; 49(2):397-401. PubMed ID: 1849199
    [No Abstract]   [Full Text] [Related]  

  • 76. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intrafamilial spread of hepatitis C virus.
    Riestra Menéndez S; Rodríguez García M; Sánchez San Román F; Menéndez Tévar F; Suárez González A; Alvarez Navascués C; Pérez Alvarez R; Rodrigo Sáez L
    Infection; 1991; 19(6):431-3. PubMed ID: 1726166
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis C virus screening: UK Blood Transfusion Service on the threshold.
    Barbara JA; Contreras M
    Med Lab Sci; 1991 Jul; 48(3):171-4. PubMed ID: 1724056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis C--screening of blood donations.
    Walsh TJ
    Ir Med J; 1991 Jun; 84(2):41-2. PubMed ID: 1716620
    [No Abstract]   [Full Text] [Related]  

  • 80. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.
    Irving WL; Neal KR; Underwood JC; Simmonds PN; James V
    BMJ; 1994 Mar; 308(6930):695-6. PubMed ID: 8142794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.